Provided by Tiger Trade Technology Pte. Ltd.

Kura Oncology

11.38
+0.07500.66%
Volume:389.71K
Turnover:4.45M
Market Cap:1.01B
PE:-3.38
High:11.52
Open:11.31
Low:11.31
Close:11.30
52wk High:13.90
52wk Low:7.36
Shares:88.77M
Float Shares:70.60M
Volume Ratio:0.48
T/O Rate:0.55%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.3668
EPS(LYR):-3.1784
ROE:-167.71%
ROA:-31.30%
PB:20.85
PE(LYR):-3.58

Loading ...

Kura Oncology CFO Jennifer Fulk Files Initial Beneficial Ownership Statement

Reuters
·
Sep 11

Kura Oncology (KURA) Receives a Buy from Leerink Partners

TIPRANKS
·
Sep 10

Kura Oncology Launches Caspian Therapeutics, Targets Clinical Proof-of-Concept for Diabetes Drug KO-7246 After USD 50 Million Financing

Reuters
·
Sep 09

Kura Oncology Launches Caspian Therapeutics with $50 Million Financing to Advance Menin Inhibition as a Potential Disease-Modifying Approach for Diabetes

THOMSON REUTERS
·
Sep 09

Kura Oncology Names Jennifer Fulk Finance Chief

MT Newswires Live
·
Sep 08

Kura Oncology Appoints Jennifer Fulk as New CFO

TIPRANKS
·
Sep 08

Kura Oncology Names Jennifer Fulk Chief Financial Officer

Dow Jones
·
Sep 08

Kura Oncology Appoints Jennifer Fulk as Chief Financial Officer

THOMSON REUTERS
·
Sep 08

Kura Oncology Grants Stock Options for 48,450 Shares to Four New Employees at $12.89 Each

Reuters
·
Sep 04

Kura Oncology Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Sep 04

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Sep 04

Is Kura Oncology's (KURA) Zacks Upgrade Quietly Reframing Its Precision Oncology Risk‑Reward Story?

Simply Wall St.
·
Sep 02

Kura Oncology to Participate in Three Investor Conferences in September

GlobeNewswire
·
Sep 01

Kura Oncology (KURA) Receives a Buy from Mizuho Securities

TIPRANKS
·
Aug 31

Kura Oncology Shares Rise After CEO Purchases 100,000 Shares

MT Newswires Live
·
Aug 26

Kura Oncology CEO buys $1.24M in common stock

TIPRANKS
·
Aug 25

Kura Oncology CEO Troy Wilson Acquires 100,000 Common Shares Valued at $1,239,000

Reuters
·
Aug 25

Kura Oncology Chief Commercial Officer Brian T. Powl Sells 4,345 Common Shares for USD 51,656.85

Reuters
·
Aug 25

Kura Oncology Price Target Maintained with a $24.00/Share by Citizens

Dow Jones
·
Aug 24

UBS Remains a Buy on Kura Oncology (KURA)

TIPRANKS
·
Aug 21